Financials China Health Group Limited

Equities

673

BMG2107P2040

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 04:08:20 2024-04-26 am EDT 5-day change 1st Jan Change
0.88 HKD -3.30% Intraday chart for China Health Group Limited +1.15% -10.20%

Valuation

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Capitalization 1 451.4 315.2 335.3 244.3 211.1 536.5
Enterprise Value (EV) 1 407.2 285.1 327.6 250.3 220.6 524.8
P/E ratio -12.5 x -13.5 x -9.1 x -31.1 x -17.2 x -11.4 x
Yield - - - - - -
Capitalization / Revenue 18.6 x 9.8 x 7.43 x 2.78 x 1.97 x 7.02 x
EV / Revenue 16.8 x 8.86 x 7.25 x 2.85 x 2.06 x 6.87 x
EV / EBITDA -12.6 x -14.3 x -12.9 x -26.1 x -26.3 x -51.9 x
EV / FCF -18.4 x -4.92 x -127 x -14.9 x 6.59 x 1,168 x
FCF Yield -5.45% -20.3% -0.79% -6.71% 15.2% 0.09%
Price to Book 2.8 x 2.42 x 3.46 x 2.57 x 2.65 x 6.12 x
Nbr of stocks (in thousands) 363,995 409,395 413,995 413,995 413,995 478,995
Reference price 2 1.240 0.7700 0.8100 0.5900 0.5100 1.120
Announcement Date 7/30/18 7/31/19 7/29/20 7/30/21 7/31/22 7/30/23
1HKD in Million2HKD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net sales 1 24.25 32.18 45.16 87.89 107 76.41
EBITDA 1 -32.24 -19.93 -25.42 -9.591 -8.378 -10.11
EBIT 1 -33.67 -21.6 -27.37 -12.18 -11.3 -12.82
Operating Margin -138.85% -67.13% -60.6% -13.86% -10.56% -16.78%
Earnings before Tax (EBT) 1 -36.72 -19.92 -34.34 -5.331 -8.709 -39.38
Net income 1 -39.25 -23.08 -36.68 -7.744 -12.2 -42.05
Net margin -161.86% -71.72% -81.22% -8.81% -11.4% -55.02%
EPS 2 -0.0990 -0.0570 -0.0890 -0.0190 -0.0296 -0.0986
Free Cash Flow 1 -22.19 -57.92 -2.575 -16.8 33.47 0.4494
FCF margin -91.5% -179.96% -5.7% -19.12% 31.27% 0.59%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 7/30/18 7/31/19 7/29/20 7/30/21 7/31/22 7/30/23
1HKD in Million2HKD
Estimates

Balance Sheet Analysis

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - 6.07 9.43 -
Net Cash position 1 44.2 30.2 7.73 - - 11.7
Leverage (Debt/EBITDA) - - - -0.633 x -1.126 x -
Free Cash Flow 1 -22.2 -57.9 -2.57 -16.8 33.5 0.45
ROE (net income / shareholders' equity) -29% -15.7% -30.7% -6.54% -9.85% -44.2%
ROA (Net income/ Total Assets) -10.6% -6.13% -8.3% -3.67% -3.18% -3.58%
Assets 1 368.7 376.5 441.8 210.9 383.5 1,173
Book Value Per Share 2 0.4400 0.3200 0.2300 0.2300 0.1900 0.1800
Cash Flow per Share 2 0.1100 0.0700 0.0200 0.0100 0.0200 0.0200
Capex 1 0.26 - 0.43 1.84 0.8 1.37
Capex / Sales 1.06% - 0.95% 2.09% 0.74% 1.79%
Announcement Date 7/30/18 7/31/19 7/29/20 7/30/21 7/31/22 7/30/23
1HKD in Million2HKD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 673 Stock
  4. Financials China Health Group Limited